FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: generic drugs

Sort
E.g., 2013-05-21
E.g., 2013-05-21
Enter a comma separated list of user names.

Par Pharmaceuticals is one of the smaller soldiers in the highly competitive generic drugs industry. Despite an excellent industry outlook, it will be an uphill battle for Par to generate outsized economic returns.

Google Inc. (NASDAQ:GOOG) previously announced financial results for the quarter ended September 30, 2010. Google reported revenues of $7.29 billion in the third quarter of 2010, representing a 23% increase over third quarter 2009 revenues of $5.94 billion. Google reports its revenues, consistent with GAAP, on a gross basis without deducting TAC.

Martin Hutchinson analyses what a Democrat landslide means for investors. He says nuclear and clean energy stocks, auto manufacturers, generic drug producers and muni bonds are a “buy”. But fossil fuel companies and financial institutions should be avoided.

ADVERTISE WITH US